<html>
<head>PUBMED IDs for DRAK1</head>
<body bgcolor='#C5F0F2'><h1>DRAK1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10629061/'>Death-associated protein kinase-related protein 1, a novel serine/threonine kinase involved in apoptosis.</a> January 11  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11279167/'>rDrak1, a novel kinase related to apoptosis, is strongly expressed in active osteoclasts and induces apoptosis.</a> March 30  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/14611687/'>Retinoblastoma protein (pRB) was significantly phosphorylated through a Ras-to-MAPK pathway in mutant K-ras stably transfected human adrenocortical cells.</a> November 13  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15254690/'>Dysregulation of apoptosis is a major mechanism in the lymph node involvement in colorectal carcinoma.</a> July 16  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/18302252/'>Gene expression analysis of major lineage-defining factors in human bone marrow cells: effect of aging, gender, and age-related disorders.</a> February 28  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21489989/'>Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells.</a> August 2  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/25531329/'>Cytoplasmic DRAK1 overexpressed in head and neck cancers inhibits TGF-Î²1 tumor suppressor activity by binding to Smad3 to interrupt its complex formation with Smad4.</a> December 17  2014<br></body></html>
